Clinical profile of childhood
Guillain-Barre Syndrome
Meshram
R. M1, Bokade C. M2, Merchant S3, Abhisheik S4, Agrawal H5, Dhakne S6
1Dr Rajkumar M. Meshram, Associate Professor, 2Dr C. M. Bokade,
Professor & Head, 3 Dr Saira Merchant, Professor, 4Dr S.
Abhisheik, Assistant Professor, 5Dr Hina Agrawal, PG Student, 6Dr
Samadhan Dhakne, PG Student. All are affiliated Department of
Paediatrics, Government Medical College, Nagpur, Maharashtra (India).
Address for
Correspondence: Dr Rajkumar M. Meshram, Associate
Professor, Department of Paediatrics Government Medical
College, Nagpur, Maharashtra (India). Email:
dr_rajmeshram@rediffmail.com
Abstract
Objective:
Recognizing the clinical presentation of Guillain–Barre
syndrome in children. Design:
Retrospective observational study. Setting:
Pediatric wards and Paediatric Intensive Care Unit. Method: A medical
record files of 52 patients of GBS, between the periods of March 2011
to February 2016 were recovered from Medical Record and Statistics
Section of institute. Files were analyzed for demographic data,
clinical features, co-morbid conditions, investigations,
electrophysiological data, mode and result of treatment and data was
analyzed. Result:
In our series males are outnumber to female and most of the patients in
age group 6-12 years, 48% were belongs to lower socioeconomic status.
In 53.8% patients antecedents were present at the beginning of clinical
picture and upper respiratory tract infection (28.84%) &
diarrohea (19.23%) was noted with predominant occurrence in monsoon
season (52%). Bilateral lower limb weakness was noted in all patients
and in 61.9% patients were common complaint pain in lower limb. Cranial
nerve involvement was evident in 28.85% and bulbar involvement was
commonest followed by facial nerve. A 23.07% patients were presented
with respiratory involvement, 9 of them (15.38%) were needed assisted
ventilation. Dysautonomic sign/symptoms were present in 26.92% with
73.33% had demyelinating pattern of neuropathy and 9.6% mortality. Conclusion: The
clinical characteristics of GBS in children are not consistent and
differ from geographical area and racial diversity.
Key Words:
Guillain Barre Syndrome, Antecedent Factors, Acute Demyelinating
Polyneuropathy, Clinical Profile
Manuscript received:
15th May 2016, Reviewed: 27th
May 2016
Author Corrected; 11th
June 2016, Accepted for
Publication: 25th June 2016
Introduction
Since poliomyelitis has been nearly been eliminated, the Guillain
–Barry Syndrome (GBS) is currently the most frequent cause of
acute flaccid paralysis worldwide and constitutes one of the serious
emergency in neurology [1]. The earliest description of GBS dates to
19th century regarding an afebrile generalized paralysis by Wardrop and
Ollivier in 1834. Other important landmarks are Landry’s
report in 1859 about an acute, ascending, predominantly motor paralysis
with respiratory failure, leading to death [2] and Osler’s
(1892) description of afebrile polyneuritis[3]. Guillain, Barre and
Strohl (1916) described a benign polyneuritis with albumin-cytological
dissociation in the cerebrospinal fluid [4] and the first report
regarding pathology of GBS was by Haymaker and Kernohan in 1949 who
reported that edema of the nerve roots was an important change in the
early stages of the disease [5]. Asbury, Arnasonand and Adams (1969)
established that the essential lesion is due to perivascular
mononuclear inflammatory infiltration of the roots and nerves [6].
Global annual incidence is reported to be 0.6-2.4 cases per lakh
population per year [7, 8]. It increases in incidence with age and
there is a small predominance of male [9]. In North America and Europe,
typical patients with GBS usually have the demyelinating variant termed
acute inflammatory demyelinating polyneuropathy (AIDP) accounts for up
to 90% of cases [10 ], whereas in China, Japan, Bangladesh and Mexico,
the frequency of axonal Guillain-Barre syndrome ranges from 30-65% and
the frequency of demyelinating GBS ranges from 22 to 46% [11,12]. There
is a paucity of comparable data from India.
Etiology of GBS is not completely understood but believes to be due to
autoimmuno cause where majority of cases are triggered by infection
stimulating anti-ganglioside antibody production. Two third of cases
are preceded by symptoms of upper respiratory tract infection or
diarrohea. The most frequent identified infectious agent associated
with subsequent development of Guillain-Barre syndrome is Campylobacter
jejuni, Cytomegalovirus, Epstein-Barr virus, Varicella-Zoster virus and
mycoplasma pneumonia [1]. Administration of outmoded antirabies vaccine
A/New Jersey (swine flu) influenza vaccine given in 1976 was associated
with slight increase in GBS incidence. New influenza vaccine appears to
confer risk of <1 per million and are relatively safe [13, 14].
Clinical features of Guillain-Barre syndrome include parasthesia,
numbness, and pain in limbs, progressive bilateral and relatively
symmetric weakness of limbs, usually ascending type with generalized
hyporeflexia or areflexia. Lower limbs are affected more than upper
limbs. Sensory involvement, cranial nerve involvement and autonomic
dysfunction including fluctuating blood pressure, tachyarrhythmia,
bradyarrhythmia, abnormal sweating are also common in childhood GBS.
Respiratory failure requiring mechanical ventilation is a serious short
term complication and leading cause of mortality in paediatric
population. Seasonal variation have also been noted in occurrence of
GBS cases [15].A common misconception is that the Guillain-Barre
syndrome has good prognosis-but up to 20% of patients remain severely
disabled and approximately 5% die , despite immunotherapy[16 ]
Material
& Methods
This series of patient with Guillain-Barre syndrome were
retrospectively studied at one of the largest tertiary care &
referral hospital that provide care to underprivileged,
socioeconomically deprived population of central India from March 2011
to February 2016. The medical records were recovered by the medical
case files from the Medical Record Section and Statistical Service of
the institute and the information was collected to conform to a
pre-established protocol after approval from institutional ethical
committee. The medical records were analyzed for the demographic data,
clinical features, co-morbid conditions, investigations,
electrophysiological data, mode and result of treatment. We classified
our patients according to Modified Kuppuswamy’s Socioeconomic
Scale into Lower , middle and upper socioeconomic class [17].
Medical Research Council (MRC) sum score was used for evaluating the
muscle strength from 0 to 5 in proximal and distal muscle in upper and
lower limb bilaterally. Cranial nerve involvement was noted along with
respiratory muscle weakness which was assessed by need of mechanical
ventilation and oxygen administration. Sensory system and autonomic
abnormalities were also analyzed.
Statistical analyses: The data regarding the numerical variables were
summarized through average, medium and deviation pattern. Categorical
data were summarized and presented inform of frequency. The frequencies
comparison between the two sexes was accomplished by the binomial test.
The P<0.05 was considered significant.
Results
Total 52 patients were enrolled from March 2011 to February2016,
27(52%) male and 25(48%) female, without significant
difference between two sexes. The age of onset varies from 9 months to
12 years with a mean age 5.76 years. A 25(48%) patients were belongs to
lower socioeconomic status while 20(38.46%) were middle class and
7(13.40%) from upper socioeconomic class. The presence of antecedents
at the beginning of the clinical picture was referred in 28(53.85%)
patients (Table 1); among them, the most frequent was upper respiratory
tract infection (28.84%) followed by diarrohea.. Time between the
antecedents and the beginning of
symptoms varied from 2 to 60 days.
Table-1: Distribution of
antecedents at the beginning of the clinical picture
Antecedents
factor
|
Frequency
|
%
|
Absent
|
24
|
46.15
|
URTI
|
15
|
28.84
|
Diarrohea
|
10
|
19.23
|
Vaccine
|
1
|
1.92
|
Hepatitis
|
2
|
3.85
|
Total
|
52
|
100
|
Seasonal occurrence in GBS is prominent in monsoon (June to September)
27(51.92%), followed by summer ( March to May) 10 (19.23%),
post monsoon (October, November) 8(15.39 %) and winter (December to
February) 7(13.46 %). (Figure 1)
In relation to clinical presentation all patients presented with
bilateral lower limb weakness. In 2(3.85%) patient fever was reported
at the beginning of the symptoms. The clinical course was increased in
50(96.15%) of the patient. Involvement of cranial nerve was present in
15(28.85%) and details of affected cranial nerve shows in these
patients are shown in Table 2.
Table-2: Cranial Nerve
Involvement
Cranial
Nerve
|
Frequency
|
%
|
III
|
2
|
13.33
|
VI
|
1
|
6.67
|
VII
|
5
|
33.33
|
IX, X
|
7
|
46.67
|
Total
|
15
|
100
|
A 12(23.07%) patient presented with respiratory involvement, 9 of them
(15.38%) needed assisted ventilation.
In 12 patient (23.07%), there were one or more signs/symptoms of
sphincter disturbances (Figure 2); pain was present in 21(40.38%),
involving more frequently the legs followed by arms, lumber and
cervical area (Table 3); Dysautonomic signs and symptoms (Table 4) were
disclosed in 14(26.92%) patients. All patients had decreased or
abolished deep reflex response of the legs and arms.
Table-3: Distribution of
Pain in location
Site
|
n
|
%
|
Inferior limb
|
13
|
61.91
|
Superior limb
|
4
|
19.05
|
Lumbar
|
2
|
9.52
|
Cervical
|
1
|
4.76
|
Abdominal
|
1
|
4.76
|
Total
|
21
|
100
|
Table-4: Dysautonomic
Sign and symptoms
Dysautonomic
sign
|
n
|
%
|
Increase BP
|
8
|
57.14
|
Hyperemia
|
3
|
21.43
|
Tachycardia
|
2
|
14.29
|
Hypothermia
|
1
|
7.14
|
Total
|
14
|
100
|
All patients underwent lumber puncture in order to analyze cell count
and the total protein. Hypercytosis was defined as WBC count
>4cell/cumm and protein concentration >40mg/dl. The
result of CSF analysis is exposed in Table 5.
Table-5: Distribution of
patient according to CSF cell & total protein concentration
Cells
|
N
|
%
|
Total
protein
|
N
|
%
|
Normal
|
37
|
71.15
|
Normal
|
0
|
0
|
Mild to moderate
|
15
|
28.85
|
Mild to moderate
|
45
|
86.54
|
High/ Intense
|
0
|
0
|
High
|
7
|
13.46
|
Total
|
52
|
100
|
total
|
52
|
100
|
Figure-2: Distribution of
sign and symptoms of sphincter disturbances
In 15 patient, electromyography and nerve conduction was performed that
disclosed a demyelination pattern in 11(73.33%), a purely motor axonal
in 3(20%) and a mixed type in 1(6.67%). All patients with demyelinating
pattern had complete recovery. Total 5 (9.61%) patient died in study
group.
Discussion
Guillain-Barre syndrome was defined more than a century back but the
clinical characteristics in children from different studies are not
consistent, which might be due to geographical and racialdiversity,
even the clinical characteristics in pediatric GBS differ from that in
adult ones [8,18]. Hence it is imperative that data from pediatric
cohort is separately evaluated. We bring a result of retrospectively
collected data on clinical profile in Indian children. In our study
males are outnumbered to female as it has been shown in various studies
that there is a small predominance of male in occurrence of GBS
cases[1,8,15,18]. Age is an important factor determining outcome and
prognosis in children and is said to be favorable as compared to adults
[8]. In childhood it is usually occurs after the age of 3 years [19].
In this series, the age varied from 9 months to 12 years and more
commonly in the age group 6 years to 12 years, similar distribution of
age was reported by Wu X et al [20] in their study. Socioeconomically
most of our patients (48%) were from lower class and 38.46% were from
middle class. Such a high occurrence of GBS in our series might be
because of our institute served to socioeconomically deprived
population and might be the incidence of infections are more common in
such socioeconomic class. There is paucity of data related to incidence
of GBS and socioeconomic condition. Seasonal or monthly variation in
the occurrence of GBS is noted in our study. In our study most of the
patients presented to us in monsoon (June to September) followed by
summer. Similar types of observations were reported by Sharma G et al
and Mathew T et al [15, 21]. The reason for this disparity remains
unclear and still need further elucidation. It is noteworthy that the
microbiological data was not available due to the retrospective nature
of our study. Whether the seasonal variation correlates to different
pathogens, which might be asymptomatic or lead to non specific
symptoms, warrants further elucidation. A previous infection should
always be searched particularly when trying to define the presence of
some agents more frequently related to GBS. In 53.85% of patients of
this series there was a report of a clinical events before the first
symptoms of GBS. Among these events the most frequent was unspecific
upper respiratory tract infection followed by diarrohea. Most of the
studies in literature noted that antecedent’s factors
associated with occurrence of GBS and most commonly URTI and diarrohea
[1, 7, 20, 22].
In relation with clinical presentation, the main feature is progressive
bilateral and relatively symmetric weakness that progresses over a
period of 12 hours to 28 days before a plateau is reached. Patients
typically have generalized hyporeflexia or areflexia. The involvement
of cranial nerves occurred in 28.85%patients. IX, X nerve being most
commonly attacked; that fact has not different to that found in
literature [20]. The respiratory involvement (23.07%), as well as
mechanical ventilation need (15.38%) were similar that reported by van
der Linden et al [19].
Pain was present in 40.38%, more frequently in the inferior limbs and
it was an important cause of irritability in smaller children to
accomplish the neurological examination, delaying in the diagnosis in
some cases. van der Linden had reported 62.3% of patients were
presented with pain in their study. Our reported incidence of pain
might be lower than actual proportion in that some children could not
describe their symptoms.
Dysautonomic sign and symptoms were present in 26.92% of the patients,
the most frequent changes being sphincter disturbances and the systemic
arterial hypertension. Similar types of autonomic disturbances were
reported by Chatterjee et al and van den Linden et al [18, 19]. But
tachycardia is most frequently reported in literature, which was not
evident in this series. That fact may be due to greater need of
monitoring. In few patients may develop severe bradyarrthymias which
are recognized cause of infrequent death from the syndrome [9].
In this series 5 patients died giving a mortality of 9.6%. Among that
all patients were presented with respiratory involvement, bulbur
involvement and needed mechanical ventilation and died inspite of
appropriate management. Our results were comparable with various
studies [7,8].
CSF examination was performed in all patients and CSF protein was
increased in all patients. Abnormal rise of CSF protein in GBS may be
due to inflammatory reaction in the choroid plexus or disturbance in
process of transport or breakdown of the blood CSF barrier [7].
Only 15 patients were subjected to electromyography and nerve
conduction study. In 73.33% presented a demyelinating pattern, 20% with
an axonal pattern and 6.67% with a mixed pattern. Our results were
comparable with van der Linden et al, Wu X et al and Sudulagunta et al.
Conclusion
The clinical characteristics of GBS in children are not consistent and
differ from geographical area and racial diversity. Males are outnumber
to female with more than 50% patients had antecedents at the beginning
of clinical picture and most commonly occurred in monsoon season. Pain
was the common associate complaint with bilateral ascending lower limb
weakness. Bulbular involvement, autonomic dysfunction, CSF pleuocytosis
and 9.61% mortality were recorded in our series.
Funding:
Nil, Conflict of
interest: Nil
Permission from IRB:
Yes
References
1. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J
Med. 2012 Jun 14;366(24):2294-304. doi: 10.1056/NEJMra1114525. [PubMed]
2. Landry J.B. Note sur la paralysie aigue. Gaz Hebd Med Chir.
1859;6:472-474. Landry J.B. Note sur la paralysie aigue. Gaz Hebd Med
Chir. 1859;6:486-488.
3. Osler W. The principles and practice of medicine: Designed for the
use of practioners and students of medicine. NewYork; Appleton:1892.
4. Guillain G, Barry J, Strohl A. Sur un syndrome de radiculonevrite
avec hyperalbuminose du liquid cephalo-rachidien sans reaction
cellulaire. Remarques sur les caracteres cliniques et graphiques des
reflexes tendineux. Bull Mem Soc Med Hop Paris. 1916; 40:1462-70.
5. Haymaker WE, Kernohan JW. The Landry-Guillain-Barry syndrome; a
clinicopathologic report of 50 fatal cases and a critique of the
literature. Medicine (Baltimore). 1949; 28(1); 59-141. [PubMed]
6. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in
idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore)
1969; 48(3):173-215. [PubMed]
7. Sudulagunta SR, Sodalagunta MB, Sepehrar M, Khorram H,Bangalore Raja
SK, Kothandapani S, et al. Guillain –Barre Syndrome: clinical
profile and management . Ger Med Sci 2015;13:Doc 16.doi:10.3205/000220.
[PubMed]
8. Kalra V, Sankhyan N, Sharma S, Gulati S, Choudhry R, Dhawan B.
Outcome in childhood Guillain –Barre Syndrome. Indian J
Pediatr 2009;76(8):795-799. [PubMed]
9. Winer JB. An update in Guillain- Barre syndrome. Autoimmuno disease
2014, Article ID 793024, 6 pages.http://dx.doi.org/10.1155/2014/793024.
10. Hadden RDM, Cornblath DR, Hughes RAC, Zielasek J, Hartnug HP, Toyka
KV et al. Electrophysiological classification of Guillain
–Barre syndrome: clinical association and outcome. Ann Neurol
1998; 44(5):780-788.Doi:10.1002/ana.41044051
11. Islam Z, Jacobs BC, van Belkum A, Mohammad QD, Islam MB, Herbrink P
et al. Axonal variant of Guillain- Barre syndrome associated with
Campylobacter infection in Bangladesh. Neurology 2010; 74(7):581-7.
Doi:10.1212/WNL.0b013e318cff735.
12. Nachamkin I, Arzarte Barbosa P, Ung H, Lobato C, Gonzalez Rivera
A,Rodriguez P et al. Patterns of Guillain- Barre syndrome in children:
results from Mexican population. Neurology 2007;69(17):1665-71. [PubMed]
13. Lehmann HC, Hartnug HP, Kieseier BC, Hughes RAC. Guillain-Barre
syndrome after exposure to influenza virus. Lancet Infect Dis
2010;10(9):643-51.doi:10.1016/S1473-3099(10)70140-7 . [PubMed]
14. Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J,
Sturkenboom M. Guillain-Barre syndrome and adjuvanted pandemic
influenza A (H1N1) 2009 vaccine: multinational case-control study in
Europe. BMJ 2011 July 12; 343:d3908. Doi:10.1136/bmj.d3908. [PubMed]
15. Sharma G, Sood S, Sharma S. Seasonal , age & gender
variation of Guillain-Barre syndrome in a tertiary referral centre in
India.Neuroscience & Medicine 2013;4:23-28.
16. Hughes RA, Swan AV, Raphel JC, Annane D, van Koningsveld R, van
Doorn PA. Immunotherapy for Guillain-Barre syndrome: a systematic
review. Brain 2007 Sep;130(Pt 9):2245-57. [PubMed]
17. Chatterjee A, Barman A, Das KM, Mandal PK, Sarkar UK, Ballav A, Pal
S. Rehabilitative outcome and its predictors in Guillain-Barre
syndrome. IJPMR 2009;20(2):37-43.
18. Bairwa M, Rajput M, Sachdeva S. Modified Kuppuswamy’s
Socioeconimic scale: Social researcher should include updated income
criteria, 2012. Indian J Community Med 2013;38(3):185-6. Doi:
10.4103/0970-0218.116358.
19. Van der Linden V, da Paz JA, Casella EB, Marques-Dias MJ.
Guillain-Barre syndrome in children: clinical and epidemiological
studyof 61 patients. Arq Neupsiquiatr 2010;68(1):12-17. [PubMed]
20. Wu X, Shen D, Li T, Zhang B, Li C, Mao M, et al. Distinct Clinical
Characteristics of Pediatric Guillain-Barre syndrome: A Comparative
Study between Children and Adults in Northeast China. PLos ONE
2016;11(3): e0151611.doi:1371/journal.pone.0151611. [PubMed]
21. Mathew T, Srinivas M, Nadig R, Arumugam R, Sarma GRK. Seasonal and
monthly trends in the occurrence of Guillain-Barre syndrome over a
5-year period: A tertiary care hospital –based study from
South India. Annals of Indian Academy of Neurology 2014;17(2):239-241. [PubMed]
22. Hu MH, Chen CM, Lin KL, Wang HS, Hsia SH, Chou ML ,et al. Risk
factors of Respiratory failure in children with Guillain-Barre
syndrome. Pediatr Neonatol 2012;53(5):295-299.
Doi:10.1016/j.pedneo.2012.07.003. [PubMed]
How to cite this article?
Meshram R. M, Bokade C. M, Merchant S, Abhisheik S, Agrawal H, Dhakne
S. Clinical profile of childhood Guillain- Barre Syndrome. Int J
Pediatr Res.2016;3(6):427-432.doi:10.17511/ijpr.2016.6.10.